ArticleBMC cancer2005
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes.
Pilar Zambrano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
57 papers cite it
this papertrialcites it